Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

Antiphospholipid syndrome is an autoimmune disorder characterized by vascular
thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody …

Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …

Abstract Beta-2-Glycoprotein I (β2GPI) plays a number of essential roles throughout the
body. β2GPI, C-reactive protein and thrombomodulin are the only three proteins that …

Aim To analyse the clinical features, laboratory data and foetal-maternal outcomes, and
follow them up on a cohort of 1000 women with obstetric antiphospholipid syndrome …

Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence
of antiphospholipid antibodies (aPL). The antibodies currently included in the classification …

Repurposing of antirheumatic drugs has garnered global attention. The aim of this article is
to overview available evidence on the use of widely used antirheumatic drugs …

Background The optimal treatment of women with primary antiphospholipid syndrome (APS)
is still debated. About 20–30% of women with APS remain unable to give birth to healthy …

Preeclampsia (PE) is a pregnancy-specific disorder affecting 4–10% of all expectant women.
It greatly increases the risk of maternal and foetal death. Although the main symptoms …